Represented ThinkEquity, as underwriter, in connection with the planned IPO of Cortigent.
Loeb is representing ThinkEquity in all aspects of Cortigent’s IPO, including corporate, FDA regulatory, IP due diligence and other matters.
-
-
Co-Chair, Life Sciences
-